Evidence map›Paper›PMID 41458795›Full record

ArticleCureus2025

Shaking in Darkness: Posterior Reversible Encephalopathy Syndrome (PRES)-Induced Acute Bilateral Blindness and Seizures.

Lauren A Gould, Adam Vytykac, Matthew Carman, Jesse Dubey

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lauren A GouldEmergency Medicine, Lakeland Regional Hospital, Lakeland, USA.
Adam VytykacEmergency Medicine, Lakeland Regional Hospital, Lakeland, USA.
Matthew CarmanEmergency Medicine, Lakeland Regional Health, Lakeland, USA.
Jesse DubeyEmergency Medicine, Lakeland Regional Health, Lakeland, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Posterior reversible encephalopathy syndrome (PRES) is a neurologic disorder that causes acute or subacute cerebral edema, brain capillary leakage, and a hyperperfusion encephalopathy that results in presenting symptoms of headache, vision changes, seizure activity, altered mentation, nausea or vomiting, or focal neurologic deficits. We describe a case of PRES in the setting of severe hypertension presenting with total blindness and seizure activity in a patient with multiple risk factors. The patient had previous episodes of PRES in the past that led to the development of a seizure disorder. We also provide a summarization table of PRES pathophysiology, symptoms, risk factors, diagnostics, treatment, and sequelae. Early consideration and expedited diagnosis of PRES are paramount, as seizures and permanent deficits are avoidable with early treatment and intervention. Seizures occur in the majority of patients presenting with PRES and are associated with an increased risk of developing epilepsy, more so than those following strokes. Timely anti-hypertensives as well as anti-convulsant therapy form the basis of treatment for PRES, allowing for prompt treatment and hopefully avoidance of long-term sequelae, including seizure disorders and permanent neurologic deficits.

Indexed as

acute blindnesscerebral hyperperfusion syndromeneurological symptoms due to hypomagnesemiaposterior reversible encephalopathy syndrome (pres)risk of seizuresevere hypertensionstroke mimic

Identifiers

PMID41458795
PMCPMC12743572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.